Alzheimer's disease, Butyrylcholinesterase inhibitors, β-amyloid, aggregation, Drug-likeness, fluorene scaffold
Amaryllidaceae alkaloid, Alzheimer's Disease, butyrylcholinesterase, Enzyme inhibition, cytotoxicity